GMK Revision
Device Knee
General payments
$234,921
Research payments
$8,573
Through program year 2023, $234,921 in general payments and $8,573 in research payments were reported against GMK Revision (Knee).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $108,964 | 103 |
| 2022 | General | $26,516 | 50 |
| 2021 | General | $74,231 | 46 |
| 2020 | General | $14,175 | 18 |
| 2020 | Research | $4,286 | 2 |
| 2019 | General | $11,034 | 32 |
| 2019 | Research | $4,286 | 3 |
Breakdown
The top 5 of 47 recipients; each share is of general payments naming this product in 2023.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
249 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.